Teva Pharmaceutical Industries files Form 8-K
Teva filed a Form 8-K on November 3.
Related stories
Western Investment Raises $55.87 Million in Share Private Placement
M impact | EQUITY | Nov 03, 2026, 04:36 PM UTC
Teva Reports Q3 Results and Raises 2026 Outlook
Teva reported Q3 revenue of $4.395 billion and adjusted EPS of $0.86. It raised its 2026 revenue outlook to $16.7 billion–$17.0 billion and adjusted EPS guidance to $1.92–$2.11.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC
Centurion to Resume Trading and Updates on Brothers Gold Project Option
Centurion says trading will resume and provides an update on its option to acquire the Brothers Gold Project in Suriname.
M impact | EQUITY | Nov 03, 2026, 04:30 PM UTC
Western Raises Over $55.8 Million From Private Placement
Western said it raised gross proceeds of over $55.8 million upon closing a previously announced private placement.
M impact | EQUITY | Nov 03, 2026, 04:30 PM UTC
Alphabet Plans $1.5 Billion Prepaid Energy Deal, Bloomberg Reports
Bloomberg reports that Alphabet plans a $1.5 billion prepaid energy deal arranged by Goldman.
M impact | EQUITY | Nov 03, 2026, 04:29 PM UTC
US Stocks Mixed; Nasdaq Rises About 1%
The Nasdaq rose about 1%, the S&P 500 advanced and the Dow edged lower. Technology led S&P 500 sectors, while consumer staples lagged.
M impact | EQUITY | Nov 03, 2026, 04:29 PM UTC